A New Risk Factor for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy?

[Figure: see text]

Detalles Bibliográficos
Autores principales: Thavendiranathan, Paaladinesh, Sacher, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830213/
https://www.ncbi.nlm.nih.gov/pubmed/36636452
http://dx.doi.org/10.1016/j.jaccao.2022.11.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830213/
https://www.ncbi.nlm.nih.gov/pubmed/36636452
http://dx.doi.org/10.1016/j.jaccao.2022.11.010

Ejemplares similares